Hassan A A, Hassouna M M, Taketo T, Gagnon C, Elhilali M M
Urology Research Laboratory, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.
J Urol. 1993 Jan;149(1):148-54. doi: 10.1016/s0022-5347(17)36028-7.
The effect of streptozotocin induced diabetes and sabeluzole (SBZ) on sexual function was evaluated in male rats. SBZ is a benzothiazole derivative with antihypoxic and antiischaemic activities. Rats were rendered diabetic by intraperitoneal injection of streptozotocin, 60 mg./kg. body weight, and either left untreated or treated with 1.0 mg./kg. of SBZ. Two groups of control rats treated with or without SBZ were also evaluated. Seven weeks after the induction of diabetes, all rats were studied in vivo for mating behavior. Animals were sacrificed one week later, and detrusor strip response in vitro was evaluated. The reproductive organ weight, sperm content and motility as well as in vitro testosterone secretion and serum levels of LH and testosterone were determined. Diabetes induced significant reduction in mating behavior. The diabetic rats that received SBZ showed a significant improvement in mating behavior. The percentage of animals that exhibited ejaculation was 0% in the diabetic group compared to 70% in the controls and 38% in diabetic plus SBZ group. The strips of the detrusor muscle of the diabetic group showed a marked hypersensitivity to bethanechol HCL. In the diabetic plus SBZ group, the strips of the detrusor muscle showed a response similar to that of the control. The diabetic rats had significantly diminished reproductive organ weight, testicular sperm content, epididymal sperm content and sperm motility relative to the control. In addition, marked decrease in the serum level of testosterone and in vitro testosterone secretion was observed in diabetic rats. In the diabetic plus SBZ group, the reproductive organ weight, sperm content and motility as well as serum testosterone and in vitro testosterone secretion showed an improvement compared to diabetic rats. In summary, our data suggest that sex behavior and reproductive tract functions are markedly affected by streptozotocin induced diabetes. Sabeluzole treatment could be beneficial in reducing the deleterious effect of diabetes on sexual functions.
评估链脲佐菌素诱导的糖尿病和沙贝鲁唑(SBZ)对雄性大鼠性功能的影响。SBZ是一种具有抗缺氧和抗缺血活性的苯并噻唑衍生物。通过腹腔注射60mg/kg体重的链脲佐菌素使大鼠患糖尿病,然后将其分为未治疗组或用1.0mg/kg的SBZ治疗组。还评估了两组分别接受或未接受SBZ治疗的对照大鼠。糖尿病诱导7周后,对所有大鼠进行体内交配行为研究。1周后处死动物,评估体外逼尿肌条反应。测定生殖器官重量、精子含量和活力以及体外睾酮分泌和血清促黄体生成素(LH)和睾酮水平。糖尿病导致交配行为显著减少。接受SBZ治疗的糖尿病大鼠在交配行为方面有显著改善。糖尿病组射精动物的百分比为0%,而对照组为70%,糖尿病加SBZ组为38%。糖尿病组逼尿肌条对盐酸贝胆碱表现出明显的高敏反应。在糖尿病加SBZ组中,逼尿肌条的反应与对照组相似。与对照组相比,糖尿病大鼠的生殖器官重量、睾丸精子含量、附睾精子含量和精子活力显著降低。此外,糖尿病大鼠的血清睾酮水平和体外睾酮分泌明显下降。在糖尿病加SBZ组中,与糖尿病大鼠相比,生殖器官重量、精子含量和活力以及血清睾酮和体外睾酮分泌均有所改善。总之,我们的数据表明,链脲佐菌素诱导的糖尿病对性行为和生殖道功能有显著影响。沙贝鲁唑治疗可能有助于减轻糖尿病对性功能产生的有害影响。